company background image
INDEX logo

InDex Pharmaceuticals Holding OM:INDEX Stock Report

Last Price

kr0.29

Market Cap

kr155.5m

7D

0.7%

1Y

-27.6%

Updated

28 Mar, 2024

Data

Company Financials

InDex Pharmaceuticals Holding AB (publ)

OM:INDEX Stock Report

Market Cap: kr155.5m

INDEX Stock Overview

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis.

INDEX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

InDex Pharmaceuticals Holding AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for InDex Pharmaceuticals Holding
Historical stock prices
Current Share Pricekr0.29
52 Week Highkr0.93
52 Week Lowkr0.20
Beta-0.23
1 Month Change4.66%
3 Month Change14.06%
1 Year Change-27.63%
3 Year Change-83.48%
5 Year Change-96.48%
Change since IPO-95.83%

Recent News & Updates

Recent updates

We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate

Jul 11
We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate

We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Jan 21
We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Aug 31
We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation

Mar 29
Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation

InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.

Feb 04
InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.

How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?

Dec 21
How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?

Shareholder Returns

INDEXSE PharmaceuticalsSE Market
7D0.7%-1.0%-0.6%
1Y-27.6%74.7%13.4%

Return vs Industry: INDEX underperformed the Swedish Pharmaceuticals industry which returned 81.6% over the past year.

Return vs Market: INDEX underperformed the Swedish Market which returned 17.1% over the past year.

Price Volatility

Is INDEX's price volatile compared to industry and market?
INDEX volatility
INDEX Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement6.1%
10% most volatile stocks in SE Market12.9%
10% least volatile stocks in SE Market3.5%

Stable Share Price: INDEX has not had significant price volatility in the past 3 months.

Volatility Over Time: INDEX's weekly volatility has decreased from 13% to 5% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20007Jenny Sundqvisthttps://www.indexpharma.com

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company’s lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences for the treatment of various immunological diseases.

InDex Pharmaceuticals Holding AB (publ) Fundamentals Summary

How do InDex Pharmaceuticals Holding's earnings and revenue compare to its market cap?
INDEX fundamental statistics
Market capkr155.54m
Earnings (TTM)-kr95.26m
Revenue (TTM)kr97.51m

1.6x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INDEX income statement (TTM)
Revenuekr97.51m
Cost of Revenuekr4.16m
Gross Profitkr93.35m
Other Expenseskr188.61m
Earnings-kr95.26m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 08, 2024

Earnings per share (EPS)-0.18
Gross Margin95.74%
Net Profit Margin-97.70%
Debt/Equity Ratio0%

How did INDEX perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.